COVID-19 in heart transplant recipients – infection rate – clinical course - immunogenity

• Conditions: covid-19heart transplant; Z94.1; Heart transplant status

• Registration Number: DRKS00023957
• Lead Sponsor: Herz- und Diabeteszentrum NRW, Klinik für Thorax-und Kardiovaskularchirurgie, Universitätsklinikum der Ruhr Universität Bochum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-22
• Study Completion: 2021-06-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients after heart transplantation

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim is to record the course of heart transplanted patients during the SARS-COV-2 pandemic with regard to risk of infection, clinical course in case of infection as well as course of antibody formation after having undergone infection and, if necessary, after vaccination.

Secondary Outcome Measures

Name	Time	Method
Observational study/ no defined endpoint/ no intervention